Most Read Articles
Roshini Claire Anthony, 16 Oct 2017

Treatment failure in osteoporosis remains a problem, even among patients who are treatment-adherent, according to a presentation at the recent meeting of the Asian Federation of Osteoporosis Societies (AFOS 2017), held in Kuala Lumpur, Malaysia. 

Elvira Manzano, 6 days ago
Bisphosphonates have proven antifracture efficacy and remain to be the cornerstone of osteoporosis treatment. However, a drug holiday is of particular importance with bisphosphonates due to some signals with long-term use of the drug, including rare incidence of atypical femoral fracture (AFF) and osteonecrosis of the jaw (ONJ), says a leading endocrinologist at AFOS 2017.
Yesterday
Drinking coffee, whether caffeinated or decaffeinated, is associated with a reduced risk of cardiovascular disease (CVD) and ischaemic heart disease (IHD) mortality in patients with a prior myocardial infarction (MI), according to a recent study.
2 days ago
Breast cancer patients have notably different microbiomes in the local breast tissue and urinary tract, a recent study reveals. Particularly, species in the Methylobacterium genus are reduced in the local breast tissue while the urinary tract is enriched in gram-positive bacteria.

ONO-8539 a novel therapeutic option for managing heartburn

12 Oct 2017

The novel prostanoid EP1 receptor antagonist ONO-8539 appears to attenuate acid-induced heartburn in healthy men, suggesting that EP1 receptors play a role in generating heartburn symptoms, according to a study.

A total of 20 males were randomized to receive either ONO-8539 (450 mg) or placebo, administered once 4 hours prior to acid perfusion test, during which hydrochloric acid at 0.15 mol l−1 was perfused into the lower oesophagus for half an hour.

Acid perception threshold was calculated as the time to first sensation of heartburn. Severity of upper gastrointestinal (GI) symptoms was assessed using a validated categorical rating scale. Upper GI symptoms of interest included heartburn, sour or bitter taste, pricking pain in the stomach, dull pain in the stomach, heavy feeling in the stomach, tight feeling in the stomach, nausea, and sensation of fullness.

Results revealed that compared with placebo, ONO-8539 significantly reduced total heartburn symptom score, but not other upper GI symptom scores, during acid perfusion (area under the curve, 56.5 with ONO-8539 vs 85.0 with placebo; p<0.01).

Furthermore, the time to first sensation of heartburn was significantly prolonged with ONO-8539 vs placebo (9.7 vs 4.3 minutes; p<0.05).

The present data show ONO-8539 as a potential novel therapeutic option for controlling heartburn symptoms in patients with gastro-oesophageal reflux disease.

ONO-8539 inhibits the EP1 receptor, which is one of the prostaglandin E2 (PGE2) receptors. In particular, oesophageal PGE2 plays an essential role in the induction and generation of heartburn symptoms in humans. Such mechanism of action of ONO-8539 has been classified as ‘‘insurmountable’’ and ‘‘competitive,’’ characterized by a long duration of inhibitory effect due to slow dissociation from the receptors. [Am J Physiol Gastrointest Liver Physiol 2013;304:G568–73]

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 16 Oct 2017

Treatment failure in osteoporosis remains a problem, even among patients who are treatment-adherent, according to a presentation at the recent meeting of the Asian Federation of Osteoporosis Societies (AFOS 2017), held in Kuala Lumpur, Malaysia. 

Elvira Manzano, 6 days ago
Bisphosphonates have proven antifracture efficacy and remain to be the cornerstone of osteoporosis treatment. However, a drug holiday is of particular importance with bisphosphonates due to some signals with long-term use of the drug, including rare incidence of atypical femoral fracture (AFF) and osteonecrosis of the jaw (ONJ), says a leading endocrinologist at AFOS 2017.
Yesterday
Drinking coffee, whether caffeinated or decaffeinated, is associated with a reduced risk of cardiovascular disease (CVD) and ischaemic heart disease (IHD) mortality in patients with a prior myocardial infarction (MI), according to a recent study.
2 days ago
Breast cancer patients have notably different microbiomes in the local breast tissue and urinary tract, a recent study reveals. Particularly, species in the Methylobacterium genus are reduced in the local breast tissue while the urinary tract is enriched in gram-positive bacteria.